Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Melissa C Larson"'
Autor:
Jithma P. Abeykoon, Paul J. Hampel, Rebecca L. King, Adam J. Wood, Melissa C Larson, Kevin E. Nowakowski, Saurabh S. Zanwar, Surendra Dasari, Gordon J. Ruan, Aishwarya Ravindran, Linda E. Wellik, Jonas Paludo, Brian K. Link, James R. Cerhan, Stephen M. Ansell, Grzegorz S. Nowakowski, Carrie A Thompson, Matthew J. Maurer, Kerstin Wenzl, Anne J. Novak, Xiaosheng Wu, Thomas M. Habermann, Thomas E. Witzig
Publikováno v:
Haematologica, Vol 106, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/4bbc3c43c423489c91c120dad843ed3f
Autor:
Melissa S DeRycke, Melissa C Larson, Asha A Nair, Shannon K McDonnell, Amy J French, Lori S Tillmans, Shaun M Riska, Saurabh Baheti, Zachary C Fogarty, Nicholas B Larson, Daniel R O'Brien, John C Cheville, Liang Wang, Daniel J Schaid, Stephen N Thibodeau
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0214588 (2019)
Prostate cancer (PrCa) is highly heritable; 284 variants have been identified to date that are associated with increased prostate cancer risk, yet few genes contributing to its development are known. Expression quantitative trait loci (eQTL) studies
Externí odkaz:
https://doaj.org/article/2589453335314bebb8adc2f586c7b6d4
Autor:
Yanina Natanzon, Madalene Earp, Julie M Cunningham, Kimberly R Kalli, Chen Wang, Sebastian M Armasu, Melissa C Larson, David DL Bowtell, Dale W Garsed, Brooke L Fridley, Stacey J Winham, Ellen L Goode
Publikováno v:
Cancer Informatics, Vol 17 (2018)
High-grade serous ovarian cancer (HGSOC) is a complex disease in which initiation and progression have been associated with copy number alterations, epigenetic processes, and, to a lesser extent, germline variation. We hypothesized that, when summari
Externí odkaz:
https://doaj.org/article/31cd03d3bb974908b07e7d1e5094531a
Autor:
Abraham Peedicayil, Robert A Vierkant, Lynn C Hartmann, Brooke L Fridley, Zachary S Fredericksen, Kristin L White, Elaine A Elliott, Catherine M Phelan, Ya-Yu Tsai, Andrew Berchuck, Edwin S Iversen, Fergus J Couch, Prema Peethamabaran, Melissa C Larson, Kimberly R Kalli, Matthew L Kosel, Vijayalakshmi Shridhar, David N Rider, Mark Liebow, Julie M Cunningham, Joellen M Schildkraut, Thomas A Sellers, Ellen L Goode
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8884 (2010)
We previously identified a panel of genes associated with outcome of ovarian cancer. The purpose of the current study was to assess whether variants in these genes correlated with ovarian cancer risk.Women with and without invasive ovarian cancer (74
Externí odkaz:
https://doaj.org/article/648526af92b44d78a476b835cd03f754
Autor:
Juan Pablo Alderuccio, Isildinha M. Reis, Jean L. Koff, Melissa C. Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M. Habermann, Peter Martin, Jennifer R. Chapman, Christopher Strouse, Brad S. Kahl, Jonathon B. Cohen, Jonathan W. Friedberg, James R. Cerhan, Christopher R. Flowers, Izidore S. Lossos
Publikováno v:
Blood. 141:1888-1893
Autor:
Surbhi Sidana, Cristine Allmer, Melissa C. Larson, Amylou Dueck, Kathleen Yost, Rahma Warsame, Gita Thanarajasingam, James R. Cerhan, Jonas Paludo, S. Vincent Rajkumar, Thomas M. Habermann, Grzegorz S. Nowakowski, Yi Lin, Morie A. Gertz, Thomas Witzig, Angela Dispenzieri, Wilson I. Gonsalves, Stephen M. Ansell, Carrie A. Thompson, Shaji K. Kumar
Publikováno v:
JCO oncology practice. 18(8)
PURPOSE: Patients' concerns regarding clinical trial (CT) participation include apprehension about side effects, quality of life (QoL), financial burden, and quality of care. METHODS: We prospectively evaluated the experience of patients with multipl
Molecular classification and identification of an aggressive signature in low‐grade B‐cell lymphomas
Autor:
Melissa A. Hopper, Kerstin Wenzl, Keenan T. Hartert, Jordan E. Krull, Abigail R. Dropik, Joseph P. Novak, Michelle K. Manske, MaKayla R. Serres, Vivekananda Sarangi, Melissa C. Larson, Matthew J. Maurer, Zhi‐Zhang Yang, Jonas Paludo, Ellen D. McPhail, Thomas M. Habermann, Brian K. Link, Lisa M. Rimsza, Stephen M. Ansell, James R. Cerhan, Dragan Jevremovic, Anne J. Novak
Publikováno v:
Hematological Oncology.
Autor:
Larry M. Karnitz, S. John Weroha, Aaron S. Mansfield, Scott H. Kaufmann, Ann L. Oberg, George Vasmatzis, Melissa C. Larson, Husheng Ding, Rebecca L. Kelly, Amelia M. Huehls, Valentina Zanfagnin, Thomas L. Ekstrom, Xiaonan Hou, Arun Kanakkanthara
Supplementary Table 1 showing qRT-PCR primer sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e2c42e300a522164db04b4b1adc7bbf
https://doi.org/10.1158/0008-5472.22582409
https://doi.org/10.1158/0008-5472.22582409
Autor:
Larry M. Karnitz, S. John Weroha, Aaron S. Mansfield, Scott H. Kaufmann, Ann L. Oberg, George Vasmatzis, Melissa C. Larson, Husheng Ding, Rebecca L. Kelly, Amelia M. Huehls, Valentina Zanfagnin, Thomas L. Ekstrom, Xiaonan Hou, Arun Kanakkanthara
PARP inhibitors (PARPi) have activity in homologous recombination (HR) repair-deficient, high-grade serous ovarian cancers (HGSOC). However, even responsive tumors develop PARPi resistance, highlighting the need to delay or prevent the appearance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e677b242d96f856734272a99d21e154
https://doi.org/10.1158/0008-5472.c.6570575.v1
https://doi.org/10.1158/0008-5472.c.6570575.v1
Autor:
Larry M. Karnitz, S. John Weroha, Aaron S. Mansfield, Scott H. Kaufmann, Ann L. Oberg, George Vasmatzis, Melissa C. Larson, Husheng Ding, Rebecca L. Kelly, Amelia M. Huehls, Valentina Zanfagnin, Thomas L. Ekstrom, Xiaonan Hou, Arun Kanakkanthara
Supplementary Materials and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6416fe0aa2cfef5dc69fe7a060f4b72
https://doi.org/10.1158/0008-5472.22582412.v1
https://doi.org/10.1158/0008-5472.22582412.v1